Cameras in Indian Pharma Plants: GMP, Data Integrity and What Auditors Look For
Nothing in India's revised Schedule M requires CCTV. Cameras are not a GMP control, and no auditor awards points for owning them. But WHO, EU and US-FDA inspectors treat video as evidence — of gowning discipline, line clearance and whether records were written contemporaneously. Point cameras at behaviour, never at batch records or lab screens.
You run a formulations or API plant somewhere between Baddi, Ahmedabad, Hyderabad, Pithampur or Aurangabad, with 200 to 1,000 people on the rolls. You export, or you want to. You have just been through — or are about to go through — a Schedule M upgrade, and a customer auditor has asked whether you have "video coverage of the gowning area." This page is about what that actually means, and where it can backfire.
Key points
- Schedule M was rewritten, and the runway has closed. The revised Schedule M was notified as G.S.R. 922(E) on 28 December 2023 (CDSCO gazette notifications). Smaller units got extra time; CDSCO has since asked state regulators to inspect and act on non-compliant units under ₹250 crore turnover, with 1 January 2026 as the effective date for those that applied for an extension.
- The revised text says nothing about cameras. It mandates a Pharmaceutical Quality System, Product Quality Review, quality risk management, computerised system validation and data integrity discipline. CCTV is not in it. Anyone selling you cameras as "Schedule M compliance" is selling you a story.
- Enforcement is real, not theoretical. The health ministry told Parliament in December 2024 that over 400 show-cause notices and licence-cancellation orders had been issued after risk-based inspections at 500-plus premises since the end of 2022.
- Your buyers' auditors are the real driver. India exported US$30.4 billion of drugs and pharmaceuticals in FY25 — roughly ₹2.6 lakh crore — and the plants earning that money get audited by customers, not just by the drug controller.
- The bar is ALCOA+. WHO's Guideline on data integrity, TRS 1033 Annex 4 sets the expectation that data be attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring and available. Video does not satisfy any of those for a batch record. It can, however, contradict one.
- The upgrade money is large; the camera money is small. Industry estimates put a medium-sized unit's Schedule M compliance cost at more than ₹1–2 crore. A camera system is a rounding error next to HVAC and utilities — spend on the cleanroom first.
- Cameras are personal data now. The DPDP Rules, 2025 were notified on 13 November 2025 and took effect on 14 November 2025, with the substantive obligations — notice, retention limits, minimisation, security — enforced from 14 May 2027. Worker footage is personal data; see our DPDP and worker CCTV guide.
Does Schedule M or any Indian rule require CCTV in a pharma plant?
No. Read the notified text: premises, plant, equipment, PQS, PQR, QRM, validation, computerised systems, documentation. There is no clause requiring video surveillance of manufacturing areas, and no central licensing condition that makes it mandatory.
Also note what changed on the labour side: the Factories Act 1948 has been consolidated into the Occupational Safety, Health and Working Conditions Code, in force from 21 November 2025. If your consultant is still quoting Factories Act sections at you for camera obligations, they are working from an old file. Our 2026 factory camera compliance playbook covers what actually replaced it.
So why do auditors keep asking? Because in a data-integrity-suspicious world, they want independent corroboration that what your SOP says happens, happens. Video is the cheapest independent witness you can install.
Where cameras genuinely help a GMP auditor believe you
The useful zones are the ones where the failure is a behaviour, not a number.
| Zone | What video can corroborate | Cleanroom constraint | Honest risk |
|---|---|---|---|
| Gowning room / airlock, Grade C–D side | Sequence followed, no shortcuts, no double entry, correct garment change frequency | Wipe-down housing; stainless or coated, disinfectant-resistant | Recording a worker undressing — this is why you cover the change bench, not the person |
| Dispensing / weighing booth | Correct container, correct scoop, second-person verification actually present | Low-shed housing, sealed flush mount, RLAF airflow not disturbed | If the camera reads the balance display, you have created a GMP-relevant data stream |
| Line clearance before changeover | Line was physically cleared and checked before "cleared" was signed | Washdown-rated on wet lines (ampoule, syrup) | Footage that contradicts a signed clearance is now discoverable |
| Compression / packing hall | Batch changeover, reconciliation of printed foils, no stray components | Standard IP66 industrial camera is fine | Low value if you never review it |
| Warehouse, quarantine and rejected-goods cage | Nothing moved from quarantine to production without release | None | The most under-used and most defensible camera in the plant |
| QC laboratory bench | Almost nothing useful | — | Very high — see below |
For sterile operations there is one adjacent practice worth separating out: airflow visualisation ("smoke") studies. EU GMP Annex 1 (2022) expects airflow patterns to be visualised and documented under both static and dynamic operating conditions. In practice those studies are filmed, and European auditors expect to be shown the recording — but that is a validation deliverable produced once, not a CCTV system. Do not confuse the two, and do not let a vendor bundle them.
For general placement logic on the non-sterile side of the plant, our note on where to place cameras on a shop floor applies unchanged.
Where you must not point a camera: documentation and QC
This is the part vendors never tell you.
The moment a camera can read a batch manufacturing record, a chromatogram, an analytical balance printout or an HPLC screen, you have created a second, uncontrolled copy of GMP data. Under ALCOA+ that copy is a record. It has no audit trail, no user attribution, no controlled retention period and no validated system behind it. It sits on an NVR that anyone in the security cabin can delete.
An inspector who notices this asks one question: is this video part of your quality system, yes or no? Both answers hurt if you have not thought about it. "No" invites the follow-up about why an uncontrolled copy of GMP data exists. "Yes" means your NVR now needs computerised-system validation, access control and an audit trail like any other GxP system.
The clean answer is architectural: cameras cover people and rooms, never paper and never screens. Frame the gowning bench, not the logbook. Frame the dispensing operator's hands and the container, not the balance readout. Write it into an SOP, and write the exclusion into your camera layout drawing so the auditor sees you decided this deliberately.
The same applies to the QC lab. Put a camera in the wet lab and you have volunteered to explain, forever, why your footage does or does not show a particular injection sequence. FDA's own Data Integrity and Compliance With Drug CGMP guidance sets out what it expects of CGMP records and the systems that hold them. You do not want to add an unvalidated video annex to that conversation.
What auditors actually ask once they see the cameras
They rarely ask for footage. They ask about the system around the footage, because that reveals whether you are managing it or ignoring it.
Expect: who can view live and recorded video, and how is access controlled? How long is footage retained, and is that period written down? Can footage be deleted, and by whom, and is the deletion logged? Has anyone ever reviewed footage as part of a deviation investigation — show me the record. Is the camera in the Grade C airlock qualified, cleaned and included in the room's cleaning SOP? Does the housing shed particles?
Two answers get you into trouble. "The security agency has the password" — because your GMP area is now controlled by a third party outside your quality system. And "we only look at it when something goes wrong" — because that is exactly when someone will ask why the last thirty days were overwritten.
Retention deserves a decision, not a default. Whatever the recorder shipped with is not a policy. Our retention checklist covers how to set and document one, and the NVR versus cloud VMS comparison covers who ends up holding the keys.
The uncomfortable case: video that contradicts your paperwork
The strongest argument for cameras in an Indian pharma plant is also the most uncomfortable one. Data-integrity findings — records that were not contemporaneous, and records that went missing — are a recurring theme in foreign regulatory inspections, which is precisely why buyer auditors arrive wanting independent corroboration rather than your assurance.
Cameras in document-storage corridors, at the record archive door and along the scrap and waste-handling route are a defensible, privacy-light control. They do not watch what an analyst writes. They watch what leaves the building. If you ever have to prove that no records left your premises unrecorded, that is the footage you will want.
Be clear-eyed about the second effect: once the footage exists, it is evidence in both directions. If your QA head is not prepared to look at what it shows, do not install it.
What cameras will not do for your GMP status
- They will not close a Schedule M gap. No amount of video substitutes for an HVAC qualification, a stability chamber, a validated water system or a PQR. Fix the plant first.
- They will not make a poor batch record acceptable. ALCOA+ is about the record. Video is corroboration at best, and an inspector will not accept "the camera shows we did it" in place of a contemporaneous entry.
- They will not survive a Grade A/B environment casually. Cameras inside a classified area need qualification, a cleanable non-shedding housing and a place in your cleaning SOP. Many plants are better off covering the airlock and leaving the core alone.
- AI detection is weaker in gowned areas. Full-body gowning removes most of the visual cues that PPE and person-detection models rely on. Helmet and PPE detection that works well in an engineering workshop will behave differently in a sterile corridor — pilot it in your actual gowning room before you buy.
- They do not create discipline on their own. A camera with no review routine and no consequence is a light fitting that costs more.
- They can create a new liability. Uncontrolled footage of GMP areas, held by a security vendor, is a finding waiting to happen.
Cost, and where it sits in the Schedule M budget
Keep the proportions honest. Against a ₹1–2 crore-plus facility upgrade, a well-specified camera layout for gowning, dispensing, packing, warehouse and the record archive is a small line item — and the expensive parts are the cleanroom-grade housings for classified areas and the cabling runs, not the cameras themselves. Our breakdown of what a factory camera AI system costs in India has the ranges.
If cash is the constraint, check what technology-upgradation assistance you qualify for before you buy anything discretionary. Government support for pharma GMP upgrades is aimed at the facility itself — HVAC, utilities, qualification — and that is also the right order of spending. Confirm current scheme terms and ceilings with the Department of Pharmaceuticals or your industry association, because they change.
FAQ
Is CCTV mandatory in pharmaceutical manufacturing in India? No. The revised Schedule M under the Drugs Rules does not require CCTV anywhere in a drug manufacturing unit, and there is no central licensing condition mandating it. Cameras are a management and audit-defence choice. Separate obligations may apply for controlled-substance handling or under specific state rules, so confirm with your state drug controller.
Can I put a camera inside a cleanroom? Technically yes, with a sealed, non-shedding, disinfectant-resistant housing that is qualified and written into the room's cleaning SOP. Practically, most Indian plants get better value covering the gowning room and airlocks in Grade C/D and leaving the classified core alone, because every device inside a clean area is one more thing to justify.
Will video footage help or hurt me in an FDA or WHO audit? Both are possible. Video covering behaviour — gowning, line clearance, waste routes — supports your case. Video that can read batch records, balance displays or lab screens creates an uncontrolled copy of GMP data with no audit trail, which is a data-integrity question you do not want to answer.
How long should a pharma plant keep CCTV footage? Decide it deliberately and write it into an SOP rather than accepting the recorder's default. Match it to your investigation window — long enough that a deviation raised weeks later can still be checked. Whatever you choose, make deletion controlled and logged, and keep the credentials inside your quality organisation, not with a security agency.
Do cameras count as evidence under ALCOA+? No. ALCOA+ applies to the GMP record itself — attributable, legible, contemporaneous, original, accurate. Footage is not attributable to a signer and carries no audit trail, so it cannot replace a batch record entry. It can, however, contradict one, which is precisely why auditors find it interesting.
Does DPDP affect cameras in my plant? Yes. Worker footage is personal data under the DPDP Act, with the Rules effective from 14 November 2025 and the substantive duties enforced from 14 May 2027. You need a stated purpose, restricted access, a retention limit and reasonable security. Gowning and change areas need particular care — cover the process, not the person.
JSON-LD note (for implementation): Publish with
FAQPagestructured data covering the six Q&A pairs above, and wrap the article inArticleschema (headline = title,datePublished,dateModified,about= "pharma plant CCTV GMP India"). Keep the FAQ markup text identical to the visible copy.
This guide is operational, not legal or regulatory advice. Schedule M compliance timelines, state drug-control conditions and DPDP enforcement dates are moving through 2025–26; verify against the notified text or with your regulatory affairs lead before you rely on anything here. Nothing on this page should be read as a claim that any camera product confers GMP compliance.